MetaCap

China SXT Pharmaceuticals (SXTC) vs cbdMD (YCBD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

cbdMD is the larger company by market cap ($4.4 million vs $453,907), about 9.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SXTC-87.86%YCBD-3.00%
+4%-44%-92%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SXTC versus YCBD key metrics
MetricSXTCYCBD
Share price$0.3435$0.3948
Market cap$453.91K$4.42M
1-day change-87.86%-3.00%
P/E ratio (TTM)—1.72
EPS (TTM)$-730.40$0.23
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$83,760.00$2.56
52-week low$0.31$0.38
Distance from 52-week high-100.00%-84.58%
Analyst consensus—none
Average volume4.71M433.66K
Shares outstanding1.32M11.21M
Employees5642
SectorHealth CareConsumer Discretionary
IndustryBiotechnology: Pharmaceutical PreparationsPackage Goods/Cosmetics

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • cbdMD is about 9.7 times larger than China SXT Pharmaceuticals by market value ($4.42M vs $453.91K).
  • The two companies sit in different sectors: China SXT Pharmaceuticals in Health Care and cbdMD in Consumer Discretionary.

About China SXT Pharmaceuticals

SXTC stock →

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Health Care · Biotechnology: Pharmaceutical Preparations · 56 employees

About cbdMD

YCBD stock →

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally.

Consumer Discretionary · Package Goods/Cosmetics · 42 employees

SXTC vs YCBD FAQ

Which is bigger, China SXT Pharmaceuticals or cbdMD?

cbdMD (YCBD) is larger, with a market capitalization of $4.42M compared with $453.91K for China SXT Pharmaceuticals (SXTC).

Are China SXT Pharmaceuticals and cbdMD in the same industry?

No. China SXT Pharmaceuticals is in the Health Care sector, while cbdMD is in Consumer Discretionary.

More comparisons